Jacobs Levy Equity Management, Inc Amphastar Pharmaceuticals, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$38.65 - $43.48 $6.43 Million - $7.23 Million	-166,369 Reduced 85.32%	28,616 $1.14 Million
Q1 2024 May 15, 2024	SELL	$42.85 - $63.45 $579,760 - $858,478	-13,530 Reduced 6.49%	194,985 $8.56 Million
Q4 2023 Feb 14, 2024	SELL	$44.49 - $62.93 $15.4 Million - $21.8 Million	-346,335 Reduced 62.42%	208,515 $12.9 Million
Q3 2023 Nov 16, 2023	BUY	$45.51 - $65.0 $7.81 Million - $11.2 Million	171,642 Added 44.79%	554,850 $25.5 Million
Q2 2023 Aug 14, 2023	BUY	$35.77 - $58.38 $9.19 Million - $15 Million	256,827 Added 203.22%	383,208 $22 Million
Q1 2023 May 15, 2023	SELL	$27.99 - $37.92 $1.8 Million - $2.44 Million	-64,291 Reduced 33.72%	126,381 $4.74 Million
Q4 2022 Feb 14, 2023	BUY	$27.93 - $31.27 $73,539 - $82,333	2,633 Added 1.4%	190,672 $5.34 Million
Q3 2022 Nov 15, 2022	BUY	$27.56 - $37.75 $25,079 - $34,352	910 Added 0.49%	188,039 $5.28 Million
Q2 2022 Aug 15, 2022	BUY	$29.79 - $42.29 $2.22 Million - $3.16 Million	74,613 Added 66.31%	187,129 $6.51 Million
Q1 2022 May 16, 2022	SELL	$22.96 - $36.45 $1.72 Million - $2.73 Million	-74,813 Reduced 39.94%	112,516 $4.04 Million
Q4 2021 Feb 14, 2022	SELL	$18.14 - $23.29 $250,313 - $321,378	-13,799 Reduced 6.86%	187,329 $4.36 Million
Q3 2021 Nov 15, 2021	BUY	$17.83 - $21.49 $197,039 - $237,485	11,051 Added 5.81%	201,128 $3.82 Million
Q2 2021 Aug 16, 2021	BUY	$17.11 - $20.92 $1.13 Million - $1.38 Million	65,847 Added 53.0%	190,077 $3.83 Million
Q1 2021 May 17, 2021	SELL	$17.21 - $20.65 $170,138 - $204,145	-9,886 Reduced 7.37%	124,230 $2.28 Million
Q4 2020 Feb 16, 2021	SELL	$17.76 - $21.24 $511,683 - $611,945	-28,811 Reduced 17.68%	134,116 $2.7 Million
Q3 2020 Nov 16, 2020	SELL	$17.99 - $22.22 $191,503 - $236,531	-10,645 Reduced 6.13%	162,927 $3.06 Million
Q2 2020 Aug 17, 2020	BUY	$14.25 - $22.46 $32,860 - $51,792	2,306 Added 1.35%	173,572 $3.9 Million
Q1 2020 May 15, 2020	SELL	$12.66 - $20.08 $105,571 - $167,447	-8,339 Reduced 4.64%	171,266 $2.54 Million
Q4 2019 Feb 14, 2020	BUY	$17.07 - $20.64 $38,987 - $47,141	2,284 Added 1.29%	179,605 $3.47 Million
Q3 2019 Nov 14, 2019	BUY	$19.12 - $22.62 $2.09 Million - $2.47 Million	109,189 Added 160.26%	177,321 $3.52 Million
Q2 2019 Aug 13, 2019	SELL	$18.92 - $22.96 $91,213 - $110,690	-4,821 Reduced 6.61%	68,132 $1.44 Million
Q1 2019 May 14, 2019	BUY	$19.46 - $25.28 $732,240 - $951,235	37,628 Added 106.52%	72,953 $1.49 Million
Q3 2018 Nov 14, 2018	BUY	$15.39 - $19.38 $543,651 - $684,598	35,325 New	35,325 $680,000

Others Institutions Holding AMPH

# of Institutions

280

Shares Held

36.7M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.64B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account